Abstract
A clonal cytogenetic abnormality was observed in Philadelphia chromosome-negative bone marrow cells of 6/27 chronic myeloid leukemia patients (+8 in 4, -7 in 1, and 20q- in 1) with dasatinib-induced remissions. The X-linked human androgen receptor gene assay demonstrated clonality in one additional patient. Single nucleotide polymorphism array analysis revealed somatic uniparental disomy involving chromosome 17(p12-pter) in another patient. The TP53 gene had a 5′ splice site deletion of exon 6 that caused alternative splicing, frame shifting and introduction of a premature stop codon. After three years, no patient developed myelodysplastic syndrome or acute myeloid leukemia.
Original language | English (US) |
---|---|
Pages (from-to) | 708-713 |
Number of pages | 6 |
Journal | Leukemia Research |
Volume | 34 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2010 |
Externally published | Yes |
Keywords
- Chronic myeloid leukemia
- Cytogenetics
- Dasatinib
- Myelodysplastic syndrome
- Single nucleotide polymorphism array
- TP53
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research